INVESTMENT FOCUS
HEALTHCARE & LIFE SCIENCES
We apply our deep Pharmaceutical, Clinical and Healthcare industry expertise to invest in companies that provide patients with better outcomes and an elevated life. We partner with Life Science and Healthcare companies across the globe to provide support and help drive medical innovation across the value chain with the goal to improve lives.
TECHNOLOGY
Abbhi Capital leverages our deep technology and software sector expertise to drive operational excellence and build value at every stage of our investment life cycle. We believe Software and disruptive technologies play a critical role in building a better future for the world.
REAL ESTATE
With real estate investments across the US and India, we apply our deep knowledge and expertise in seeking unique real estate opportunities to align to our core values as an investment firm. Our network of property management partners, contractors, architects and engineers allows us to expand returns on our investments and build an innovative and value add real estate portfolio.
Abbhi Capital’s current and past investments represent many leading companies across industries that play a disruptive role in creating a better future and elevating human life.
View: Active Investments | Exited Investment
Active Investments
ArisGlobal
For more than 30 years, ArisGlobal has been an established global market leader. Today, more than 300 life sciences companies, CROs and government health authorities around the world rely on ArisGlobal’s software to accomplish mission-critical tasks throughout the drug development process. Sankesh Abbhi served as President and CEO from 2017 to 2022 and now serves as a member of the Board. Abbhi Capital initially invested in ArisGlobal in 2017 and has played a key role in the successful acquisition and subsequent investments by Nordic Capital since 2019.
- CEO: Mike Gordon
- Founded: 1987
- Headquarters: Miami, FL
- Website: www.arisglobal.com
Mede Analytics
With the most advanced data orchestration in healthcare, MedeAnalytics delivers actionable insights that improve financial, operational, and clinical outcomes for payers and providers across the U.K. and U.S. With a sole focus on healthcare, MedeAnalytics was the first to market in 1994 with a healthcare analytics SaaS solution. Today, that spirit of innovation continues with a platform that features powerful analytics technologies, including machine learning, guided analysis and predictive analytics. Mede also delivers a comprehensive platform-as-a-service offering, equipping clients to build their own custom applications. Every day, MedeAnalytics empowers provider and payer organizations to achieve better outcomes by unlocking the potential of their data.
- CEO: Steve Grieco
- Founded: 1993
- Headquarters: Richardson, TX
- Website: www.medeanalytics.com
Allied Universal
Abbhi Capital has been an investor in Allied Universal® since 2021. Allied is a leading security and facility services company. They provide proactive security services and cutting-edge smart technology to deliver evolving, tailored solutions that allow their clients to focus on their core business. Operating in 90 countries, their experienced team of 800,000+ employees help to deliver our promise globally and locally: keeping people safe so our customers and communities can thrive. As we build the world’s best services company, we continue to expand our footprint and infrastructure on a global and local level.
- CEO: Steve Jones
- Founded: 1957
- Headquarters: Conshohocken, PA
- Website: www.aus.com
Wellness Real Estate Partners
Wellness Real Estate Partners invest in Behavioral Health Real Estate across the continental US. They partner with best-in-class behavioral health operating companies so they can do more of what they do best. Their model is simple: they purchase the real estate owned by a behavioral health company and, at the same time, lease the real estate back to the company in a long-term lease structure (a “sale-leaseback”). Abbhi Capital has been an investor with Real Estate Partners since 2020 and continues to grow their investment as Wellness RE expands their portfolio.
- Website: https://wellness-re.com/
Sitero
Sitero is a next-generation CRO that provides comprehensive services to guide life sciences companies through the development and execution of a clinical program, across all stages of development and life cycle management.
Sitero has experience and expertise with a diverse range of Therapeutic Areas and focus on innovative, technology enabled solutions that allow our clients to focus on their core strengths.For early phase studies through Phase III clinical trials, our experienced team delivers high-touch services and technology to ensure your trial is handled with the quality and care that results in compliant outcomes and patient focused results.
- CEO: Sankesh Abbhi
- Founded: 2022
- Headquarters: Miami, Floria
- Website: www.sitero.com
Public
Public.com is an investing platform that helps people be better investors. On Public, ownership unlocks an experience of content and education, contextual to your portfolio, created by a 3 million+ strong community of investors, creators, and analysts. They put investors first and don’t sell trades to market makers or take money from Payment for Order Flow (PFOF).
- CEO: Jannick Malling
- Founded: 2019
- Headquarters: New York, NY
- Website: www.public.com
Exited Investments
CRIO
CRIO is the leader in eSource technology with software solutions that streamline regulatory workflows with one system and one source of clinical data capture. The platform enables electronic data capture and remote monitoring with powerfully integrated solutions that protect data integrity and compliance across 21 CFR 11, ICH-GCP, GDPR, HIPPA, and other global regulations. CRIO supports a wide variety of clinical research data. Abbhi Capital initially invested in CRIO in 2016 and has worked closely with the business through the most recent Series B financing round, that Abbhi Capital led. Sankesh currently serves as a member of the CRIO Board of Directors.
- CEO: Raymond Nomizu
- Founded: 2016
- Headquarters: Boston, NY
- Website: www.clinicalresearch.io
Brain Storm Cell Therapeutics
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.
- CEO: Chaim Lebovits
- Founded: 2000
- Headquarters: New York, NY
- Website: www.brainstorm-cell.com
GET IN TOUCH
We are excited to hear about any questions, opportunities or inquiries you may have. Please follow the below link to Get In Touch and we will get back to you soon.
